In December 2024 , the FDA determined that AOD-9604 (both free base and acetate forms) should not be included on the 503A Bulks List for pharmaceutical compounding, citing concerns over limited long-term safety data, peptide impurities, and potential immunogenicity
[5] In summary, pyridoxine may decrease the efficacy of certain medications (notably levodopa and some anticonvulsants), and various drugs can in turn precipitate vitamin B deficiency
Use only the diluent specified by the manufacturer or dispensing pharmacy. How is peptide contamination reduced during reconstitution and handling
Adherence to local and international safety protocols, including SDS handling and PPE
Aliquoting Protocol Decide on a volume per aliquot based on your typical experiment size (e.g., 50100 L per aliquot) Use low-binding microcentrifuge tubes (protein low-bind or equivalent) Label each tube: compound name, concentration, date, lot number Flash freeze aliquots in liquid nitrogen or dry ice/ethanol bath before transferring to -80C storage Discard any aliquot that has been thawed and refrozen more than once See: Optimal Storage and Stability Guidelines for IGF-1 LR3 Lyophilized Research Peptide for detailed post-reconstitution storage guidance
Tilt the syringe at a 30-degree angle so that the oil draws out of the needle in a flow, rather than dripping
